Featured
Read our handpicked blogs, curated for you.
|
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to…
|
Pharma marketing in India is at a turning point. Budgets have expanded, channels have multiplied, and compliance…
|
If you’re serious about HCP Engagement Tier 2 Cities, stop chasing metro playbooks. Tier 2 doctors don’t sit in front…
Recent releases
|
The Real Cost of CRM Silos: Missed Doctors, Missed Prescriptions
CRM silos are killing our marketing effectiveness. You and I both know it. We’ve all invested in CRMs, detailing apps, email platforms, and even WhatsApp campaigns. However, when these…
|
Reinventing Medical Education: From Decks to Doctor Communities
For decades, the pharmaceutical industry’s idea of medical education has remained largely unchanged, consisting of PowerPoint decks, glossy brochures, and occasional in-person CME events. But the…
|
Creative Won’t Save Pharma Marketing. Execution Will.
Pharma marketing doesn’t fail because of weak ideas. It fails because execution breaks down. In a regulated, crowded, and compliance-heavy industry, even the smartest campaign can collapse without…
|
Doctor Engagement: The KPI Every CMO Should Have on Their Dashboard
The Metric That Actually MattersPharma marketing is drowning in dashboards. Clicks. Impressions. Call volumes. Email opens. Webinar registrations. The screens look busy, but when the board asks the…
